In our study, we found that IL-17RC depletion abrogated rhIL-17A-induced EGFR activation, suggesting that IL-17A-enhanced EGFR activation is dependent on IL-17R in EGFR-mutant NSCLC cells. This evidence concerns the gene IL17RA and non-small cell lung carcinoma.